Gastroenterology
News, opinions and meeting coverage in gastroenterology.
β Investigational drug filgotinib demonstrated limited efficacy in DIVERSITY study
Latest in Gastroenterology
Prevention and screening efforts accounted for 80% of those averted deaths
23% achieved HBsAg loss with xalnesiran plus immunomodulator, but relapses occurred in some
Zenocutuzumab achieved response rates of 40% in pancreatic adenocarcinoma, 33% in advanced NSCLC
23% achieved HBsAg loss with xalnesiran plus immunomodulator, but relapses occurred in some
Zenocutuzumab achieved response rates of 40% in pancreatic adenocarcinoma, 33% in advanced NSCLC
Gastroenterology Case Studies
Discordant test results complicate diagnosis of suspected C. difficile
Moral of the story: don't walk barefoot in the fields
Clinicians found CT scan to be best diagnostic tool
More in Gastroenterology
Nearly half of women with unusual or nonreportable cfDNA-sequencing results had cancer
Liver cancer risk higher among men, while cirrhosis more common in women
Limited life expectancy may not increase acceptance of such guidelines, researchers say
All drugs except one remained more expensive in the U.S.
Also in TTHealthWatch: minimum effective dose of pneumococcal vaccines
Absence of gut function recovery is the primary reason for extended hospital stays
Study also showed the monoclonal antibody was noninferior to ustekinumab
Previously, such transplants could be done only as part of research studies
In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug
The answer may have more to do with how we track them, experts say
Ways to avoid food-related danger during the holidays
"Top down" vs "step up" therapy, FDA actions, rethinking placebos, and new tulisokibart data
Elevated risk of IBD for people exposed to environmental pollutants in the prior decade
